Treatment of allergic rhinitis

Annals of Medicine

Volumn 28, Issue 1, 1996, Pages 17-22

  Suonpää, Jouko ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Allergy; Antihistamines; Corticosteroids; Immunotherapy; Pharmacotherapy; Rhinitis

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; EYE DROPS; STEROID; VASOCONSTRICTOR AGENT;

ALLERGIC RHINITIS; EYE DISEASE; HUMAN; IMMUNOTHERAPY; NOSE OBSTRUCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SHORT SURVEY; TOPICAL DRUG ADMINISTRATION;

EID: 0030062767     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999069     Document Type: Short Survey

References (49)

1. Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol 1988; 82: 927-34.
2. Kaliner M, Eggleston P, Mathews K. Rhinitis and asthma. JAMA 1987; 258: 2851-73.
3. Iliopoulos O, Proud D, Adkinson NF, et al. Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 1990; 86: 851-61.
4. Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993; 48: 476-90.
5. Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol 1988; 82: 927-34.
6. International consensus report on the management and diagnosis and management of rhinitis. Allergy 1994; 49 (Suppl): 1-34.
7. Platts-Mills TAE, Chapman MD. Dust mites: immunology, allergic disease and enviromental control. J Allergy Clin Immunol 1987; 80: 755-77.
8. Munir AKM, Björkstèn B, Einarsson R, et al. Mite allergens in relation to home conditions and sensitization of asthmatic children from three climatic regions. Allergy 1995; 50: 55-64.
9. Kneist F, Wolfs B, Vos H, et al. Mechanisms and patient compliance of dust-mite avoidance regimens in dwellings of mite-allergic rhinitis patients. Clin Exp Allergy 1992; 22: 681-9.
10. Howarth P, Lunn A, Tomkins S. A double-blind, placebo controlled trial of Intervent bedding system in perennial allergic rhinitis. J Allergy Clin Immunol 1992; 89: 305.
11. DeBlay F, Chapman MD, Platts-Mills TAE. Airborne cat allergen (Fel d I): enviromental control with the cat in situ. Am Rev Respir Dis 1991; 143: 1334-9.
12. Bindslev-Jensen C. Respiratory reactions induced by food challenges in adults. Pediatr Allergy Immunol 1992; 3: 201-5.
13. Thompson RA, Bousquet J, Cohen S, et al. The current status of allergen immunotherapy. Report of a WHO/IUIS working group. Allergy 1989; 44: 369-79.
14. Georgitis JW, Reisman RE, Clayton WF, Mueller UR, Wypych JI, Arbesman CE. Local intranasal immunotherapy for grass-allergic rhinitis. J Allergy Clin Immunol 1983; 71: 71-6.
15. Bertelsen A, Andersen JB, Christensen J, Ingeman L, Kristensen T, Östergaard PA. Immunotherapy with dog and cat extracts in children. Allergy 1989; 44: 330-5.
16. Juniper EF, Kline PA, Ramsdale EH, Hargreave FE. Comparision on efficacy and side-effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex®) in the treatment of seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 1990; 85: 606-11.
17. Malling H-J, Weeke B. EAACI Position Paper. Immunotherapy. Allergy 1993; 48 (Suppl 14): 1-35.
18. Bousquet J, Becker WM, Heijjaoui A, et al. Clinical and immunological reactivity of patients allergic to grass pollens and to multiple pollen species. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extract. J Allergy Clin Immunol 1991; 88: 43-53.
19. 1-receptor antagonists: clinical pharmacology and therapeutics. J Allergy Clin Immunol 1989; 84: 845-61.
20. 1-receptor antagonists. Ann Allergy 1991; 66: 5-21.
21. 1-antihistamines on the early allergic response. Ann Allergy 1989; 63: 551-5.
22. 1-antagonists. Clin Exp Allergy 1990; 20: 3-17.
23. 1-antihistamine inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990; 142: 167-71.
24. Klementsson H, Andersson M, Pipkorn U. Allergen induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx. J Allergy Clin Immunol 1990; 86: 466-72.
25. Davies RJ, Ollier S, Cundell DR. Drug treatment for nasal allergy. Clin Exp Allergy 1989; 19: 559-68.
26. Howarth PH. How to optimise the treatment of rhinitis. Res Clin Forum 1992; 14: 75-81.
27. Davies R, Lund VJ, Harten-Ash VJ. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 1993; 31: 159-64.
28. Dechant KL, Goa KL. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 1991; 41: 202-24.
29. Davies AJ, Harindra V, McEwan A, Ghose RR. Cardiotoxic effect with convulsions in terfenadine overdose. BMJ 1989; 298: 325.
30. Simons FER. New medications for rhinitis. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Boston: Blackwell Science, 1995: 1325-36.
31. Lacroix JS. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand 1989; 136: 1-63.
32. Änggård A, Malm L. Orally administered decongestant drugs in disorders of the upper respiratory passages: a survey of clinical results. Clin Otolaryngol 1984; 9: 43-9.
33. Graf P, Hallen H, Juto J-E. Four-week use of oxymetazoline nasal spray (Nezeril®) once daily at night induces rebound swelling and nasal hyperreactivity. Acta Otolaryngol (Stockh) 1995; 115: 71-5.
34. Meran A, Morse J, Gibbs TG. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology 1990; 28: 33-40.
35. Nuutinen J, Holopainen E, Malmberg H, Rinne J, Suonpää J, Silvasti M. Terfenadine with or without phenylpropanolamine in the treatment of seasonal allergic rhinitis. Clin Exp Allergy 1989; 19: 603-8.
36. Feather I, Harrison K, Brewster H, Howarth P. The effect of seldane-D, terfenadine and pseudoephedrine on the nasal response to allergen. J Allergy Clin Immunol 1991; 87: 51.
37. Pearce FL, Al-Laith M, Bosman L, et al. Effects of sodium cromogylate and nedocromil sodium on histamine secretion from mast cells from various locations. Drugs 1989; 37 (Suppl): 37-43.
38. Okuda M, Onishi M, Ohtsuka H. The effect of cromolyn sodium on the nasal mast cells. Ann Allergy 1985; 5: 21-3.
39. Schuller DE, Selcow JE, Joos TH, et al. A multicentre trial of nedocromil sodium 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis. J Allergy Clin Immunol 1990; 86: 554-61.
40. Pipkorn U. Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis. Allergy 1983; 8: 25-9.
41. Gomez E, Clagne JE, Gotland D, Davies R. Effect of topical corticosteroids on seasonally induced rhinitis increases in nasal mast cells. BMJ 1988; 296: 1572-3.
42. Scadding GK, Lund VJ, Holmström M, Darby YC. Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1991; 11 (Suppl): 37-43.
43. Orgel HA, Meltzer EO, Bierman W, et al. Intranasal flucortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy. J Allergy Clin Immunol 1991; 88: 257-64.
44. Lindqvist N, Andersson M, Bende M, Loth S, Pipkorn U. The clinical efficacy of budenoside in hay fever treatment is dependent on topical nasal application. Clin Exp Allergy 1989; 19: 71-6.
45. Welsh PW, Stricker WE, Chu-Pin C, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clinic Proc 1987; 62: 125-34.
46. Newman SP, Moren F, Clarke SW. Deposition patterns from a nasal pump spray. Rhinology 1987; 25: 77-82.
47. Pipkorn U, Pukander J, Suonpää J, et al. Long-term safety of budenoside nasal aerosol: a 5.5 year follow-up study. Clin Allergy 1988; 18: 253-9.
48. Hedner P, Persson G. Suppression of hypothalamo-pituitary-adrenal axis after single intramuscular injection of methylprednisolone acetate. Ann Allergy 1981; 47: 176-9.
49. Mygind N, Borum P. Anticholinergic treatment of watery rhinorrhea. Am J Rhinol 1990; 4: 1-5.